Central Europe Genomics Centersp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-09-28
Share capital
6 800,00 PLN
Registered address
ul. Warszawska 6/32, 15-063 Białystok, Poland

Financials

The financial statement for 2022 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue
This companyUSD 1.94mMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD 320.87kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 1.38mMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 2.36mMedianUSD 116.77kAverageUSD 2.72m

Bank accounts

Was a VAT taxpayer from 2020-03-06 to 2023-08-30. Removed from VAT register

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

5 closed proceedings recorded in KRZ history. Closed proceedings in history

Registration dateProceeding typeStatus
Jun 23, 2025
Proceedings before the restructuring court under the Code of Civil Procedure
Closed
Feb 13, 2025
Arrangement approval proceedings
Closed
Dec 18, 2023
Discontinued enforcement proceedings
Closed
Dec 18, 2023
Discontinued enforcement proceedings
Closed
Oct 24, 2023
Discontinued enforcement proceedings
Closed

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Anna Małgorzata Borna — Management Board Member
Roman Stankiewicz — Management Board Member

Manner of representation

In the case of a multi-member management board – each member of the management board independently.

Ownership

OwnerSharesShare valueStake
36$486.2226.4706%
Dariusz Stankiewicz (47)
75$1,012.9755.1471%
25$337.6618.3824%

Beneficial owners

Person
Dariusz Stankiewicz (47)

Competitors

Name
BiotechnaS.A.
Read-GeneS.A.
Proteon PharmaceuticalsS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
RDLSsp. z o.o.
FamicordtxS.A.
Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o.
InventroS.A.
Plan Biosp. z o.o.

Change history

DateEvent
2017-01-23Address change
2016-05-13Share capital change
2015-10-20Share capital change
2015-09-28Entered in the register

FAQ

Last updated: 2026-05-28